You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

November 28, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

[BLOG]: Cost containment through the use of generic medications

Hospitals and health systems must be prepared and have the right processes in place to take full advantage of financial savings each time a brand-name medication goes generic. » Follow 5 best practices

FDA offers more guidance for "outsourcing facilities"

FDA provided additional assistance to help compounders of sterile human drugs that have registered with the agency as "outsourcing facilities" under the Drug Quality and Security Act (DQSA). » Read more about the DQSA

Continuing Education

MTM essentials for weight management

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to educate pharmacists about the prevalence, health consequences, and nonpharmacologic and pharmacologic treatment options for obesity, with a focus on the recommendations made in the 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT12-FKX42.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

Tumor treating fields with temozolomide may increase PFS in patients with newly diagnosed glioblastoma

Adding tumor treating fields (TTFields) therapy to temozolomide significantly increases progression-free survival (PFS) for newly diagnosed glioblastoma patients versus giving temozolomide alone, according to new data. » More from the Society for Neuro-Oncology (SNO) Annual Meeting in Miami

 

RELATED ARTICLES

FDA concerned about generic ADHD drugs

Compounded ingredient costs: PBMs take action

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group